Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00490893
Status:
TERMINATED
Last Update Posted:
2007-06-25
First Post:
2007-06-22
Brief Title:
Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir
Sponsor:
University Hospital Tuebingen
Organization:
University Hospital Tuebingen
Study Overview
Official Title:
Effects of Insulin Detemir Versus Regular Insulin Actrapid on Hormonal Counterregulation Cognitive Function and Symptom Perception During Hypoglycemia
Status:
TERMINATED
Status Verified Date:
2007-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hypoglycemia and unawareness of hypoglycemia are major problems of insulin therapy in patients with diabetes mellitus The long acting insulin analogue Detemir has structural and physicochemical properties which differ from human insulin The aim of the present study is to test whether this leads to altered hormone and symptom response during hypoglycemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None